RADICAVA ORS® (edaravone)
(https://radicava.com) 📸 Data Snapshot: June 19, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is strong but technically incomplete in the structured data. While the site references specific medical experts like ‘Dr. Jeffrey Rosenfeld’ and ‘Dr. Gary L Pattee,’ there is no Person schema or sameAs links to their academic or professional profiles. The Organization schema is present but basic, failing to link to the parent pharmaceutical company or clinical trial registrations.
The performance claims are exceptionally well-grounded in clinical trial data (e.g., ‘3X as many patients given RADICAVA lost 2 or less points’). Unlike most sites, this one quantifies its claims with specific safety study cohorts (‘185 patients’) and duration (‘6-month safety study’). There is no disconnect between marketing tone and demonstrated outcomes.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment."
}
/patient/
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment."
}
/patient/educational-webinar/
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/educational-webinar/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Watch neurologists and ALS specialists discuss RADICAVA ORS® (edaravone), disease management and emerging research in our on-demand webinars."
}
/patient/understanding-radicava/
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/understanding-radicava/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Review efficacy data, safety profile and patient support resources that make RADICAVA ORS® (edaravone) a treatment option for ALS."
}
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 5 | 0 |
| /patient/ | 5 | 0 |
| /patient/educational-webinar/ | 6 | 0 |
| /patient/understanding-radicava/ | 4 | 0 |
This page presents a snapshot of public data from RADICAVA ORS® (edaravone), captured on June 19, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to RADICAVA ORS® (edaravone): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://radicava.com to view the most current version of its content and see directly what this company is about and what it offers.